Keywords: generic, version, maxzide-25, approved, geneva, pharmaceutical, received
GENERIC VERSION OF MAXZIDE-25 APPROVED
Article | 25 May 1992
- Geneva Pharmaceutical has received the first generic approval of a version of Mylan's Maxzide-25 (triamterene and hydrochloro-thiazide) from the FDA. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
